Influence of cancer-related inflammation on plasma disposition of osimertinib in patients with non-small cell lung cancer using the Glasgow prognostic score.
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · 2026 · 57 (2) · 6-14
DOI: 10.3999/jscpt.57.2_6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2026. Verfasst von Tasuku YOKOYAMA und 6 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
YOKOYAMA, T., HAYASHI, N., ASADA, K., SHIRAI, T., UCHINO, T., YAZAWA, Y., & KAGAWA, Y. (2026). Influence of cancer-related inflammation on plasma disposition of osimertinib in patients with non-small cell lung cancer using the Glasgow prognostic score. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 57(2), 6-14. https://doi.org/10.3999/jscpt.57.2_6
Vancouver
YOKOYAMA T, HAYASHI N, ASADA K, SHIRAI T, UCHINO T, YAZAWA Y, et al. Influence of cancer-related inflammation on plasma disposition of osimertinib in patients with non-small cell lung cancer using the Glasgow prognostic score. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 2026;57(2):6-14. doi:10.3999/jscpt.57.2_6
BibTeX
@article{YOKOYAMA2026,
author = {YOKOYAMA, Tasuku and HAYASHI, Natsu and ASADA, Kazuhiro and SHIRAI, Toshihiro and UCHINO, Tomonobu and YAZAWA, Yasuharu and KAGAWA, Yoshiyuki},
title = {Influence of cancer-related inflammation on plasma disposition of osimertinib in patients with non-small cell lung cancer using the Glasgow prognostic score},
journal = {Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {57},
number = {2},
pages = {6--14},
doi = {10.3999/jscpt.57.2_6}
}
EUVIMED